| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.42 | 0.003 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.006 |